Andrey V. Susekov

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna D. Pradhan, Robert J. Glynn, Jean‐Charles Fruchart et al. · New England Journal of Medicine · 2022 · 711 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

Scott M. Grundy, Hidenori Arai, Philip J. Barter et al. · Journal of clinical lipidology · 2013 · 326 citations · Full text

Medicine, Cardiology, Endocrinology +16

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens et al. · Atherosclerosis · 2018 · 238 citations · Full text

Medicine, Cardiology, Genetics +11

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

John J.P. Kastelein, Kevin C. Maki, Andrey V. Susekov et al. · Journal of clinical lipidology · 2013 · 231 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +16